Want to see CALC full AI Analyst Report?
Cm-4620 Injectable Emulsion Or Cm-4620-Ie
Acute Pancreatitis, Systemic Inflammatory Response Syndrome
Phase II
Completed
A Study of Auxora in Patients With Acute Pancreatitis and Accompanying SIRS
Dec 15, 2020
―
Cm4620-Ie, Auxora
Pneumonia
Phase II
Terminated
A Study of Auxora in Patients With Critical COVID-19 Pneumonia
Dec 04, 2020
―
Auxora, Standard Of Care
Pneumonia
Phase II
Completed
A Study of Auxora in Patients With Severe COVID-19 Pneumonia
Apr 07, 2020
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does CalciMedica (CALC) have in its pipeline
CALC is currently developing the following drugs: Auxora, Cm-4620 Injectable Emulsion Or Cm-4620-Ie, Cm4620-Ie, Auxora. These drug candidates are in various stages of clinical development as the company works toward FDA approval.